Prescribed heartburn drug Zantac recalled as a 'precaution'

GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news

Related Links:

A popular form of heartburn medication may increase a person’s risk of developing COVID-19, according to a new study, lengthening the already long list of risk factors for the virus. In the study, published Tuesday in pre-print form in the American Journal of Gastroenterology, scientists led by Cedars-Sinai Medical Center’s Dr. Brennan Spiegel conducted an online survey involving more than 86,000 people. Among them, more than 53,000 reported abdominal pain or discomfort, acid reflux, heartburn or regurgitation, and answered questions about the medications they took to relieve those symptoms. Of those, more than...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
BOWEL cancer symptoms include weight loss, stomach pain, and feeling very tired for no obvious reason. But you could also be at risk of the disease if you develop persistent heartburn or indigestion. How often is it normal to feel stomach pain, and should you speak to a doctor?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Monday, April 6, 2020 (American Heart Association News) -- Doug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might have a stomach problem, but waved it off,...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Update: On April 1, 2020, the FDA requested manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs (Zantac, others) from the market immediately, due to the presence of a contaminant known as N-Nitrosodimethylamine (NDMA). Although the FDA did not observe unacceptable levels of NDMA in many of the samples they tested, they have determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures. As a result of this recall, ranitidine products will no longer be available for prescription or OTC use in the US. The FDA is also advising co...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Drugs and Supplements Source Type: blogs
New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration's (FDA's) more drastic action.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Heartburn medication made by Sanofi of France has been linked to cancer-causing impurity
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
FDA orders drugmakers to pull popular heartburn medications that contain trace amounts of a carcinogen.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
The U.S. Food and Drug Administration is telling drugmakers to immediately pull a type of heartburn drug off the market due to contamination with a chemical that may cause cancer
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Although most drugmakers had already pulled the heartburn products months ago, the agency told consumers they should throw out any over-the-counter medications they still had.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugstores Zantac Drugs (Pharmaceuticals) Food and Drug Administration Recalls and Bans of Products Heartburn Hazardous and Toxic Substances carcinogen your-feed-healthcare Source Type: news
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable cancer-causing chemical, the U.S. Food and Drug Administration said...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Heartburn